Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with …

H Orlefors, A Sundin, U Garske, C Juhlin… - The Journal of …, 2005 - academic.oup.com
Neuroendocrine tumors (NETs) can be small and situated almost anywhere throughout the
body. Our objective was to investigate whether whole-body (WB) positron emission …

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with 111In-Pentetreotide

DJ Kwekkeboom, EP Krenning, K Scheidhauer… - …, 2009 - karger.com
Dik J. Kwekkeboom a Eric P. Krenning a Klemens Scheidhauer b Val Lewington c Rachida
Lebtahi d Ashley Grossman e Pavel Vitek f Anders Sundin g Ursula Plöckinger h and the …

The Utility of 68Ga-DOTATATE Positron-Emission Tomography/Computed Tomography in the Diagnosis, Management, Follow-Up and Prognosis of Neuroendocrine …

A Tirosh, E Kebebew - Future Oncology, 2017 - Taylor & Francis
Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …

[HTML][HTML] Somatostatin receptor PET/CT imaging for the detection and staging of pancreatic NET: a systematic review and meta-analysis

M Bauckneht, D Albano, S Annunziata, G Santo… - Diagnostics, 2020 - mdpi.com
We investigated the diagnostic performance of Somatostatin Receptor Positron Emission
Tomography/Computed Tomography (SSR-PET/CT) for the detection of primary lesion and …

[HTML][HTML] The NETPET score: combining FDG and somatostatin receptor imaging for optimal management of patients with metastatic well-differentiated neuroendocrine …

E Hindié - Theranostics, 2017 - ncbi.nlm.nih.gov
Neuroendocrine tumors (NET) are often metastatic at the time of diagnosis. Metastatic well-
differentiated (G1/G2) NET may display a wide range of behaviors, ranging from indolent to …

Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic …

S Van Binnebeek, B Vanbilloen, K Baete… - European …, 2016 - Springer
Objectives To compare the diagnostic accuracy of 111 In-pentetreotide-scintigraphy with 68
Ga-DOTATOC-positron emission tomography (PET)/computed tomography (CT) in patients …

Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours

S Severi, O Nanni, L Bodei, M Sansovini… - European journal of …, 2013 - Springer
Purpose The prognostic value of FDG PET for neuroendocrine tumours (NETs) has been
reported. In this study we evaluated the role of FDG PET in predicting response and …

[HTML][HTML] Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition …

M Weber, L Kessler, B Schaarschmidt, WP Fendler… - BMC cancer, 2020 - Springer
Abstract Background Neuroendocrine tumors (NETs) frequently overexpress somatostatin
receptors (SSTRs), which is the molecular basis for 68 Ga-DOTATOC positron-emission …

PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature

CB Johnbeck, U Knigge, A Kjær - Future oncology, 2014 - Taylor & Francis
Neuroendocrine tumors have shown rising incidence mainly due to higher clinical
awareness and better diagnostic tools over the last 30 years. Functional imaging of …